Viewing Study NCT02076633

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-02-28 @ 10:35 PM
Study NCT ID: NCT02076633
Status: COMPLETED
Last Update Posted: 2015-05-27
First Post: 2014-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Intratumoral Administration of L19IL2/L19TNF
Sponsor: Philogen S.p.A.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Melanoma, Skin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None L19 View
None monoclonal View
None antibody View
None IL-2 View
None TNFα View
None Interleukin View
None Phase II View
None metastatic melanoma View
None clinical stage III View
None Clinical stage IV M1a View